PRECLINICAL DEVELOPMENT OF NOVEL PARATHYROID HORMONE-RELATED PEPTIDE ANTAGONISTS FOR BREAST CANCER

$451,500FY2016Department of the ArmyDOD

The Administrators Of Tulane Educational Fund

Investigators